NAT-ABIRATERONE
NATCO PHARMA (CANADA) INC
Quick answers
Is there a shortage of NAT-ABIRATERONE in Canada?
No. There is no current shortage of NAT-ABIRATERONE 250MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
MAR-ABIRATERONE
MARCAN PHARMACEUTICALS INC
REDDY-ABIRATERONE
DR REDDY'S LABORATORIES LTD
EUGIA-ABIRATERONE
EUGIA PHARMA INC.
MINT-ABIRATERONE
MINT PHARMACEUTICALS INC
RIVA-ABIRATERONE
LABORATOIRE RIVA INC.
DIN
02494132
Strength
250MG
Dosage Form
Tablet
Route
Oral
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from NATCO PHARMA (CANADA) INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
1MG · DIN 02417855
5MG · DIN 02492822
2.5MG · DIN 02492814
25MG · DIN 02496887
100MG · DIN 02496895
62.5MG · DIN 02467984
125MG · DIN 02467992
10MG · DIN 02496461
20MG · DIN 02496488
40MG · DIN 02409038
20MG · DIN 02409011
5MG · DIN 02439557